1. 6 Variation in practice in endometrial cancer (EC); can molecular classification direct care and reduce costs associated with management?. (13th November 2020) Authors: Thompson, E; Lum, A; Huvila, J; Scott, S; Lui, V; He, E; Salisbury, T; Keane, S; Keane, S; Samouelian, V; Irving, J; Salvador, S; Helpman, L; Wohlmuth, C; Kinloch, M; Offman, S; Vicus, D; Grondin, K; Gtlieb, W; Plante, M Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 4 Refining pathologic interpretation of endometrial carcinomas: lessons learned from a nationwide study in a new era of molecular classification. (13th November 2020) Authors: Thompson, E; Huvila, J; Leung, S; Irving, J; van der Westhuizen, N; Kinloch, M; Lytwyn, A; Sur, M; Parra-Herran, C; Yasmeen, A; Gougeon, F; Morin, C; Grondin, K; Offman, S; Salisbury, T; He, E; Lawson, J; Vanden Broek, J; Bell, C; Ennour-Idrissi, K Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S50 Once-daily glycopyrronium improves lung function in COPD patients: pooled results of the GLOW1 and GLOW2 studies. (19th November 2012) Authors: Banerji, D; Alagappan, V; Martin, C; He, E; Chen, H; Overend, T Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P194 Once-Daily QVA149 Provides Superior Bronchodilation and Improves Lung Function Versus Twice-Daily Fluticasone/Salmeterol in COPD Patients: The ILLUMINATE Study. (19th November 2012) Authors: Vogelmeier, C; Bateman, E; Pallante, J; Bryant, H; Alagappan, V; D'Andrea, P; He, E; Banerji, D Journal: Thorax Issue: Volume 67(2012)Supplement 2 Page Start: A149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 0500 Evaluation of the Human Abuse Potential of Single Oral Doses of V117957, a Novel, Highly Potent and Selective Partial Agonist for Nociceptin/Orphanin-FQ Peptide (NOP) Receptors. (27th May 2020) Authors: Harris, S; Zhou, M; Cipriano, A; Kapil, R; Shet, M; He, E; Apseloff, G Journal: Sleep Issue: Volume 43(2020)Supplement 1 Page Start: A191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 0502 Safety, Tolerability, and Efficacy of a Novel, Highly Potent and Selective Partial Agonist for Nociceptin/Orphanin-FQ Peptide (NOP) Receptors in Patients with Insomnia Disorder. (27th May 2020) Authors: Zhou, M; Harris, S; Kapil, R; Cipriano, A; He, E; Shet, M; Fukumura, K; Matsuo, Y; Uehira, M; Zammit, G Journal: Sleep Issue: Volume 43(2020)Supplement 1 Page Start: A192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 0198 Psychomotor/Cognitive Effects, Pharmacokinetics and Safety of V117957, a Novel, Highly Potent and Selective Partial Agonist for Nociceptin/Orphanin-FQ Peptide (NOP) Receptors, Administered in Combination with Alcohol in Healthy Subjects. (27th May 2020) Authors: Zhou, M; Harris, S; Cipriano, A; Kapil, R; He, E; Shet, M; Apseloff, G Journal: Sleep Issue: Volume 43(2020)Supplement 1 Page Start: A78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Differing psychological vulnerabilities among behaviourally and perinatally HIV infected adolescents in South Africa – implications for targeted health service provision*. (20th June 2018) Authors: Sherr, L.; Cluver, L. D.; Toska, E.; He, E Journal: AIDS care Issue: Volume 30(2018)Supplement 2 Page Start: 92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗